Proteasome inhibitor-induced coronary vasospasm in multiple myeloma: a case report.
Philopatir MikhailJames RogersCecily Jane ForsythThomas Joseph FordPublished in: European heart journal. Case reports (2021)
Coronary spasm is a rare but important adverse reaction to proteasome inhibitors. This case supports the clinical utility of invasive coronary vasoreactivity testing in patients with ischaemia with no obstructive coronary artery disease.
Keyphrases
- coronary artery disease
- coronary artery
- multiple myeloma
- percutaneous coronary intervention
- coronary artery bypass grafting
- cardiovascular events
- aortic stenosis
- subarachnoid hemorrhage
- high glucose
- diabetic rats
- cardiovascular disease
- emergency department
- type diabetes
- transcatheter aortic valve replacement
- adverse drug
- endothelial cells
- blood brain barrier